BioPharm International
November 01, 2014
Features
27
11
The authors take a look at some of the recent developments in the German pharmaceutical market.
November 01, 2014
Cover Story
27
11
Cellular therapy developers learn process development strategies from pharma industry experiences.
November 01, 2014
Features
27
11
The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission.
November 01, 2014
Troubleshooting
27
11
Challenges remain for virus removal and validation.
November 01, 2014
Perspectives on Outsourcing
27
11
European CDMOs want into the US market, but entry options are limited.
November 01, 2014
Products
27
11
Eppendorf's Cell Culture Consumables have an ISO class/GMP class C clean room production standard.
November 01, 2014
From the Editor
27
11
Ebola Virus Disease (EVD) is a severe, often fatal disease that is transmitted human-to-human through bodily fluids.
November 01, 2014
Regulatory Beat
27
11
Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.
November 01, 2014
Features
27
11
Defining critical parameters and processing large quantities of data can be a challenge.
November 01, 2014
Cover Story
27
11
The authors offer insight into cell therapy manufacturing, vector production, and the safety aspects of testing for characterization.
November 01, 2014
Analytical Best Practices
27
11
The ability to define a scientifically justified and statistically sound sampling procedure is a fundamental skill in modern systematic drug development.
November 01, 2014
Issue PDF
27
11
Click the title above to open the BioPharm International November 2014 issue in an interactive PDF format.